SynthesisFrontiers in immunology2021

Systematic Review of Safety and Efficacy of Second- and Third-Generation CD20-Targeting Biologics in Treating Immune-Mediated Disorders.

Celine Kaegi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.